Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction:: Role of memory B cells and CD5+ B cells

被引:77
|
作者
Blanca, IR
Bere, EW
Young, HA
Ortaldo, JR
机构
[1] NCI, Frederick Canc Res & Dev Ctr, Expt Immunol Lab, Frederick, MD 21702 USA
[2] Cent Univ Venezuela, Fac Med, Inst Inmunol, Caracas, Venezuela
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 11期
关键词
D O I
10.4049/jimmunol.167.11.6132
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
NK cells are a subpopulation of lymphocytes characterized primarily by their cytolytic activity. They are recognized as an important component of the immune response against virus infection and tumors. In addition to their cytolytic activity, NK cells also participate either directly or indirectly in the regulation of the ongoing Ab response. More recently, it has been suggested that NK cells have an important role in the outcome of autoimmune diseases. Here, we demonstrate that human NK cells can induce autologous resting B cells to synthesize Ig, including switching to IgG and IgA, reminiscent of a secondary Ab response. B cell activation by the NK cell is contact-dependent and rapid, suggesting an autocrine B cell-regulated process. This NK cell function is T cell-independent, requires an active cytoplasmic membrane, and is blocked by anti-CD40 ligand (anti-CD154) or CD40-mIg fusion protein, indicating a critical role for CD40-CD40 ligand interaction. Depletion studies also demonstrate that CD5(+) B cells (autoreactive B-1 cells) and a heterogeneous population of CD27(+) memory B cells play a critical role in the Ig response induced by NK cells. The existence of this novel mechanism of B cell activation has important implications in innate immunity, B cell-mediated autoimmunity, and B cell neoplasia.
引用
收藏
页码:6132 / 6139
页数:8
相关论文
共 50 条
  • [41] ROLE OF CD40 AND CD40 LIGAND IN T-CELL-DEPENDENT B-CELL ACTIVATION
    KEHRY, MR
    CASTLE, BE
    KISHIMOTO, K
    BROWN, ML
    WHITE, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 174 - 174
  • [42] Role of CD5+ B-1 cells in EAE pathogenesis
    Peterson, Lisa K.
    Tsunoda, Ikuo
    Fujinami, Robert S.
    AUTOIMMUNITY, 2008, 41 (05) : 353 - 362
  • [43] HUMAN CD5+ (B1) B-CELLS IN HEALTH AND DISEASE
    LYDYARD, PM
    YOUINOU, PY
    FUNDAMENTAL AND CLINICAL IMMUNOLOGY, 1994, 2 (01): : 9 - 25
  • [44] Change in activation status of circulating CD5+ and CD5- human B cells during aging.
    Damle, RN
    Sison, C
    Banapour, T
    Chiorazzi, N
    BLOOD, 2003, 102 (11) : 53B - 53B
  • [45] DECREASED CD5+ B-CELLS IN KAWASAKI-DISEASE AND INCREASED CD5+ B-CELLS AFTER IVIG TREATMENT
    NOH, GW
    KIM, DS
    FASEB JOURNAL, 1995, 9 (04): : A1032 - A1032
  • [46] All B cells are not the same: a story of CD40 activation
    Byrd, JC
    BLOOD, 2004, 104 (13) : 3847 - 3847
  • [47] The interaction of CD40 receptor on B cells with different forms of recombinant CD40L
    Byazrova, M.
    Astakhova, E.
    Spiridonova, A.
    Prilipov, A.
    Filatov, A.
    FEBS OPEN BIO, 2021, 11 : 218 - 218
  • [48] Cognate CD40-CD40L interaction is important for maintenance of thymic B cells.
    Fujihara, Chiharu
    Williams, Joy
    Jeon, Hyein
    Hodes, Richard
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [49] DIRECT PHYSICAL INTERACTION INVOLVING CD40 LIGAND ON T-CELLS AND CD40 ON B-CELLS IS REQUIRED TO PROPAGATE MMTV
    CHERVONSKY, AV
    XU, JC
    BARLOW, AK
    KHERY, M
    FLAVELL, RA
    JANEWAY, CA
    IMMUNITY, 1995, 3 (01) : 139 - 146
  • [50] Preferential localization of human CD5+ B cells in the peritoneal cavity
    Nisitani, S
    Murakami, M
    Akamizu, T
    Okino, T
    Ohmori, K
    Mori, T
    Imamura, M
    Honjo, T
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 46 (06) : 541 - 545